Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bendamustin
2. Bendamustine
3. Cytostasan
4. Hydrochloride, Bendamustine
5. Imet 3393
6. Ribomustin
7. Treanda
8. Zimet 3393
1. 3543-75-7
2. Bendamustine Hcl
3. Treanda
4. Ribomustin
5. Cytostasan
6. Sdx-105
7. Bendamustin Hydrochloride
8. Bendeka
9. Imet 3393
10. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzo[d]imidazol-2-yl)butanoic Acid Hydrochloride
11. Syb L-0501
12. Ribomustine
13. Treakisym
14. Bendamustine (hydrochloride)
15. 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic Acid Hydrochloride
16. 97832-05-8
17. Nsc-138783
18. Sdx 105
19. 3543-75-7 (hcl)
20. Sybl-0501
21. 981y8sx18m
22. Levact
23. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzo-[d]imidazol-2-yl)butanoic Acid Hydrochloride
24. 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic Acid;hydrochloride
25. Treanda (tn)
26. 1h-benzimidazole-2-butanoic Acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, Monohydrochloride
27. Bendit
28. Ccris 1864
29. Nsc 138783
30. Cytostosan
31. Innomustine
32. Symbenda
33. Benda
34. Unii-981y8sx18m
35. Treanda Hcl
36. Zimet 33/93
37. Ribomustin (tn)
38. Bendamustine Hydrochloride Injection
39. Vivimusta
40. Inno-p08001
41. Gamma(1-methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid [german]
42. Schembl18843
43. Mls006010156
44. Sdx-105 (cytostasane) Hcl
45. Chembl1201734
46. Dtxsid40188912
47. Bcpp000348
48. Bcp02107
49. Hy-b0077
50. Tox21_500623
51. Mfcd01658758
52. Nsc138783
53. S1212
54. Akos015951203
55. Ac-1619
56. Bcp9000390
57. Bendamustine Hydrochloride (jan/usan)
58. Bendamustine Hydrochloride [mi]
59. Bendamustine Hydrochloride [usan:jan]
60. Ccg-221927
61. Cs-1771
62. Ep-3101
63. Lp00623
64. Sb17462
65. 2-benzimidazolebutyric Acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, Monohydrochloride
66. 2-benzimidazolinebutryric Acid, 1-methyl-5-bis(2-chloroethyl)amino-, Hydrochloride
67. Bendamustine Hydrochloride [jan]
68. Gamma(1-methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid
69. Bendamustine Hydrochloride [usan]
70. Ncgc00261308-01
71. As-15856
72. Bb164239
73. Bendamustine Hydrochloride [mart.]
74. Bp-25399
75. Smr004234484
76. Bendamustine Hydrochloride [usp-rs]
77. Bendamustine Hydrochloride [who-dd]
78. Bendamustine Hcl (sdx-105, Cytostasane)
79. 2-benzimidazolinebutryric Acid, Hydrochloride
80. Am20090666
81. B4033
82. Ft-0650624
83. Ft-0696296
84. Sw219266-1
85. 2-benzimidazolebutyric Acid, Monohydrochloride
86. Bendamustine Hydrochloride [orange Book]
87. D07085
88. Wln: T56 Bn Dnj B1 C3vq Gn2g2g &gh
89. 543b757
90. Bendamustine Hydrochloride [usp Monograph]
91. Q27272066
92. Fmoc-(s)-3-amino-3-(3-trifluoromethyl-phenyl)-propionicacid
93. 4-(5-(bis(2-chloroethyl)amino)-1-methylbenzimidazol-2-yl)butanoic Acid Hcl
94. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzo[d]imidazol-2-yl)butanoicacidhydrochloride
95. 5-[bis(2-chloroethyl)amino]-1-methyl-1h-benzimidazole-2-butanoic Acid Hydrochloride
96. 5-[bis(2-chloroethyl)amino]-1-methylbenzimidazole-2-butyric Acid Hydrochloride
97. 1h-benzimidazole-2-butanoic Acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, Hydrochloride (1:1)
98. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzimidazole-2-yl)butanoic Acid Monohydrochloride
99. 5-[bis(2-chloroethyl)-amino]-1-methyl-1h-benzimidazole-2-butanoic Acid Hydrochloride;ribomustin Hcl
Molecular Weight | 394.7 g/mol |
---|---|
Molecular Formula | C16H22Cl3N3O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 393.077760 g/mol |
Monoisotopic Mass | 393.077760 g/mol |
Topological Polar Surface Area | 58.4 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 380 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Bendamustine hydrochloride |
PubMed Health | Bendamustine (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 100mg |
Market Status | Tentative Approval |
Company | Eagle Pharms |
2 of 4 | |
---|---|
Drug Name | Treanda |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Powder; Injectable; Solution |
Route | injection; Iv (infusion) |
Strength | 25mg/vial; 180mg/2ml (90mg/ml); 45mg/0.5ml (90mg/ml); 100mg/vial; 100mg |
Market Status | Prescription |
Company | Cephalon |
3 of 4 | |
---|---|
Drug Name | Bendamustine hydrochloride |
PubMed Health | Bendamustine (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 100mg |
Market Status | Tentative Approval |
Company | Eagle Pharms |
4 of 4 | |
---|---|
Drug Name | Treanda |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Powder; Injectable; Solution |
Route | injection; Iv (infusion) |
Strength | 25mg/vial; 180mg/2ml (90mg/ml); 45mg/0.5ml (90mg/ml); 100mg/vial; 100mg |
Market Status | Prescription |
Company | Cephalon |
Antineoplastic Agents, Alkylating
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-24
Pay. Date : 2013-09-25
DMF Number : 27483
Submission : 2013-09-20
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-03
Pay. Date : 2012-11-29
DMF Number : 24823
Submission : 2011-03-30
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm :
NDC Package Code : 55111-938
Start Marketing Date : 2011-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26721
Submission : 2014-02-24
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-10
Pay. Date : 2012-12-28
DMF Number : 26723
Submission : 2013-01-04
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-20
Pay. Date : 2012-12-19
DMF Number : 25222
Submission : 2011-11-08
Status : Active
Type : II
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-005
Start Marketing Date : 2022-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Bansen Co., Ltd.
Registration Date : 2023-03-27
Registration Number : No. 163-16-ND(A)
Manufacturer Name : Shilpa Pharma Lifesciences Limited
Manufacturer Address : Raichur Industrial Growth Centre, Plot Nos. 33, 33A, 40 to 47, Block C,D,E,H,I & AM, Chicksugur - 584 134, Dist: Raichur. Karnataka, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33380
Submission : 2018-12-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25826
Submission : 2012-02-24
Status : Active
Type : II
Registration Number : 301MF10055
Registrant's Address : Strada Rivoltana Km 6/7 20053 Rodano Milano Italy
Initial Date of Registration : 2019-08-29
Latest Date of Registration : --
NDC Package Code : 17337-0306
Start Marketing Date : 2018-11-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28501
Submission : 2014-07-27
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-24
Pay. Date : 2013-09-25
DMF Number : 27483
Submission : 2013-09-20
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-03
Pay. Date : 2012-11-29
DMF Number : 24823
Submission : 2011-03-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25394
Submission : 2011-10-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22626
Submission : 2009-03-13
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-02-25
Pay. Date : 2013-09-27
DMF Number : 25524
Submission : 2011-11-24
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-19
Pay. Date : 2013-09-18
DMF Number : 25807
Submission : 2012-03-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-24
Pay. Date : 2012-11-09
DMF Number : 25512
Submission : 2011-11-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-31
Pay. Date : 2013-01-04
DMF Number : 25800
Submission : 2012-02-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26142
Submission : 2012-06-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25826
Submission : 2012-02-24
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-y...
CAS Number : CAS-3543-72-4
End Use API : Bendamustine Hydrochloride
About The Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients ...
Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole-2-yl...
CAS Number : CAS-3543-73-5
End Use API : Bendamustine Hydrochloride
About The Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients ...
Isopropyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-...
CAS Number : CAS-1313020-26-6
End Use API : Bendamustine Hydrochloride
About The Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients ...
ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl- 1H...
CAS Number : 3543-74-6
End Use API : Bendamustine Hydrochloride
About The Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Activ...
ethyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol- 2-y...
CAS Number : 3543-73-5
End Use API : Bendamustine Hydrochloride
About The Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Activ...
Ethyl 4-(1-Methyl-5-Nitro-1H-Benzimidazol-2-yl) Bu...
CAS Number : CAS-3543-72-4
End Use API : Bendamustine Hydrochloride
About The Company : We are Rampex Labs, a fully cGMP compliant pharmaceutical intermediates plant located in the outskirts of Hyderabad, India. Our company was founded in 2004 with...
Ethyl 4-(5-Amino-1-Methyl-1H-Benzimidazol-2-yl) Bu...
CAS Number : CAS-3543-73-5
End Use API : Bendamustine Hydrochloride
About The Company : We are Rampex Labs, a fully cGMP compliant pharmaceutical intermediates plant located in the outskirts of Hyderabad, India. Our company was founded in 2004 with...
4-(5-Amino-1-Methyl-1H-Benzoimidazol-2-yl)-Butyric...
CAS Number : CAS-1313020-26-6
End Use API : Bendamustine Hydrochloride
About The Company : We are Rampex Labs, a fully cGMP compliant pharmaceutical intermediates plant located in the outskirts of Hyderabad, India. Our company was founded in 2004 with...
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Dosage Form : Bendamustina 100Mg 5 Units Paren...
Dosage Strength : 5 vials Chk 100 mg 2,5 mg/ml
Price Per Pack (Euro) : 1,382.54
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Bendamustina 100Mg 5 Units Paren...
Dosage Strength : 5 VIALS EV 100 mg 2,5 mg/ml
Price Per Pack (Euro) : 2,140.17
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Bendamustina 100Mg 5 Units Paren...
Dosage Strength : 5 VIALS EV 100 mg 2,5 mg/ml
Price Per Pack (Euro) : 1,382.54
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Bendamustina 25Mg 20 Joined The ...
Dosage Strength : 20 VIALS EV 25 mg 2.5 mg/ml
Price Per Pack (Euro) : 2,140.17
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Bendamustina 25Mg 5 Units Parent...
Dosage Strength : 5 Chk vials 25 mg 2.5 mg/ml
Price Per Pack (Euro) : 345.64
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Bendamustina 25Mg 5 Units Parent...
Dosage Strength : 5 VIALS EV 25 mg 2.5 mg/ml
Price Per Pack (Euro) : 535.05
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Bendamustina 25Mg 5 Units Parent...
Dosage Strength : 5 VIALS EV 25 mg 2.5 mg/ml
Price Per Pack (Euro) : 345.64
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Dry Sub
Dosage Strength : 100mg
Price Per Pack (Euro) : 170.78
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Dosage Form : Dry Sub
Dosage Strength : 25mg
Price Per Pack (Euro) : 219.25
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
EG SpA
Dosage Form : Bendamustina 100Mg 5 Units Paren...
Dosage Strength : 5 VIALS EV 100 mg 2,5 mg/ml
Price Per Pack (Euro) : 1,382.54
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?